Soranzo N, Sanna S, Wheeler E, Gieger C, Radke D, Dupuis J, Bouatia-Naji N, Langenberg C, Prokopenko I,

Stolerman E, Sandhu MS, Heeney MM, Devaney JM, Reilly MP, Ricketts SL, et al. Common variants at 10 ge-

nomic loci influence hemoglobin A1C levels via glycemic and nonglycemic pathways. Diabetes 2010;59:3229–3239

In the article listed above, the author names and affiliations should have appeared as follows:

Nicole Soranzo,1,2 Serena Sanna,3 Eleanor Wheeler,1 Christian Gieger,4 Dörte Radke,5 Josée Dupuis,6,7 Nabila Bouatia-Naji,8 Claudia Langenberg,9 Inga Prokopenko,10,11 Elliot Stolerman,12,13,14 Manjinder S. Sandhu,9,15,16 Matthew M.Heeney,17 Joseph M. Devaney,18 Muredach P. Reilly,19,20 Sally L. Ricketts,15 Alexandre F.R. Stewart,21 Benjamin F.Voight,12,13,22 Christina Willenborg,23,24 Benjamin Wright,25 David Altshuler,12,13,14 Dan Arking,26 Beverley Balkau,27,28

Daniel Barnes,9 Eric Boerwinkle,29 Bernhard Böhm,30 Amélie Bonnefond,8 Lori L. Bonnycastle,31 Dorret I. Boomsma,32

Stefan R. Bornstein,33 Yvonne Böttcher,34 Suzannah Bumpstead,1 Mary Susan Burnett-Miller,18 Harry Campbell,35

Antonio Cao,3 John Chambers,36 Robert Clark,37 Francis S. Collins,31 Josef Coresh,38 Eco J.C. de Geus,32 Mariano Dei,3

Panos Deloukas,1 Angela Döring,4 Josephine M. Egan,39 Roberto Elosua,40 Luigi Ferrucci,41 Nita Forouhi,9 Caroline S.Fox,7,42 Christopher Franklin,35 Maria Grazia Franzosi,43 Sophie Gallina,8 Anuj Goel,11,44 Jürgen Graessler,33 HaraldGrallert,4 Andreas Greinacher,45 David Hadley,46 Alistair Hall,47 Anders Hamsten on behalf of Procardis Consortium,48

Caroline Hayward,49 Simon Heath,50 Christian Herder,51 Georg Homuth,52 Jouke-Jan Hottenga,32 Rachel Hunter-Merrill,6

Thomas Illig,4 Anne U. Jackson,53 Antti Jula,54 Marcus Kleber,55 Christopher W. Knouff,56 Augustine Kong,57 JaspalKooner,58 Anna Köttgen,59 Peter Kovacs,60 Knut Krohn,60 Brigitte Kühnel,4 Johanna Kuusisto,61 Markku Laakso,61

Mark Lathrop,62 Cécile Lecoeur,8 Man Li,59 Mingyao Li,63 Ruth J.F. Loos,9 Jian’an Luan,9 Valeriya Lyssenko,64 ReedikMägi,10,11 Patrik K.E. Magnusson,65 Anders Mälarstig,48 Massimo Mangino,2 María Teresa Martínez-Larrad,66,67 WinfriedMärz,55 Wendy L. McArdle,68 Ruth McPherson,21 Christa Meisinger,4 Thomas Meitinger,69,70 Olle Melander,64 Karen L.Mohlke,71 Vincent E. Mooser,56 Mario A. Morken,31 Narisu Narisu,31 David M. Nathan,14,72 Matthias Nauck,73 ChrisO’Donnell,7 Konrad Oexle,69 Nazario Olla,3 James S. Pankow,74 Felicity Payne,1 John F. Peden,11,44 Nancy L. Pedersen,65

Leena Peltonen,1,75,76 Markus Perola,76,77 Ozren Polasek,78,79 Eleonora Porcu,3 Daniel J. Rader,19,20 Wolfgang Rathmann,80

Samuli Ripatti,76,77 Ghislain Rocheleau,81,82 Michael Roden,51,83 Igor Rudan,35,84 Veikko Salomaa,77 Richa Saxena,12,13

David Schlessinger,85 Heribert Schunkert,24 Peter Schwarz,33 Udo Seedorf,86 Elizabeth Selvin,38 Manuel Serrano-Ríos,66,67

Peter Shrader,87 Angela Silveira,48 David Siscovick,88 Kjioung Song,56 Timothy D. Spector,2 Kari Stefansson,89,90 ValgerdurSteinthorsdottir,89 David P. Strachan,46 Rona Strawbridge,48 Michael Stumvoll,34,91 Ida Surakka,76,77 Amy J. Swift,31

Toshiko Tanaka,41,92 Alexander Teumer,52 Gudmar Thorleifsson,57 Unnur Thorsteinsdottir,89,90 Anke Tönjes,34 GianlucaUsala,3 Veronique Vitart,49 Henry Völzke,5 Henri Wallaschofski,73 Dawn M. Waterworth,56 Hugh Watkins,11,44 H-ErichWichmann,4,93,94 Sarah H. Wild,35 Gonneke Willemsen,32 Gordon H. Williams,14,42 James F. Wilson,35 JulianeWinkelmann,69,70,95 Alan F. Wright,49 WTCCC,96 Carina Zabena,66,67 Jing Hua Zhao,9 Stephen E. Epstein,18 JeanetteErdmann,24 Hakon H. Hakonarson,97 Sekar Kathiresan,12,13,14,98 Kay-Tee Khaw,99 Robert Roberts,21 Nilesh J. Samani,47

Mark D. Fleming,100 Robert Sladek,81,82 Gonçalo Abecasis,53 Michael Boehnke,53 Philippe Froguel,8,101 Leif Groop,64 MarkI. McCarthy,10,11,102 W.H. Linda Kao,103 Jose C. Florez,12,13,14,72 Manuela Uda,3 Nicholas J. Wareham,9 Inês Barroso,1 andJames B. Meigs14,87

From 1Human Genetics, Wellcome Trust Sanger Institute, Hinxton, U.K.; the 2Department of Twin Research and Ge-netic Epidemiology, King’s College London, London, U.K.; 3Istituto di Neurogenetica e Neurofarmacologia, CNR,Monserrato, Italy; the 4Institute of Epidemiology, Helmholtz Zentrum München, German Research Center for Envi-ronmental Health, Neuherberg, Germany; the 5Institute for Community Medicine, Ernst Moritz Arndt UniversityGreifswald, Greifswald, Germany; the 6Department of Biostatistics, Boston University School of Public Health, Boston,Massachusetts; the 7National Heart, Lung, and Blood Institute’s Framingham Heart Study, Framingham,Massachusetts; 8CNRS-UMR-8090, Institut Pasteur de Lille and Lille 2 University, Lille, France; the 9MRC EpidemiologyUnit, Institute of Metabolic Science, Cambridge, U.K.; the 10Oxford Centre for Diabetes, Endocrinology and Metabo-lism, University of Oxford, Oxford, U.K.; the 11Wellcome Trust Centre for Human Genetics, University of Oxford,Oxford, U.K.; the 12Center for Human Genetic Research, Massachusetts General Hospital, Boston, Massachusetts;the 13Program in Medical and Population Genetics, Broad Institute of Harvard and MIT, Cambridge, Massachusetts;the 14Department of Medicine, Harvard Medical School, Boston, Massachusetts; the 15Public Health and Primary Care,Strangeways Research Laboratory, University of Cambridge, Cambridge, U.K.; the 16Wellcome Trust Sanger Institute,Hinxton, Cambridge, U.K.; the 17Hematology Division, Children’s Hospital Boston, Boston, Massachusetts;the 18Cardiovascular Research Institute, MedStar Research Institute, Washington Hospital Center, Washington, D.C.;the 19Institute for Translational Medicine and Therapeutics, School of Medicine, University of Pennsylvania, Philadelphia,Pennsylvania; the 20Cardiovascular Institute, University of Pennsylvania, Philadelphia, Pennsylvania; 21Medicine, Universityof OttawaHeart Institute, Ottawa, Canada; the 22Department of Molecular Biology, Massachusetts General Hospital, Boston,Massachusetts; 23Institut für Medizinische Biometrie und Statistik, Universität zu Lübeck, Lübeck, Germany; 24MedizinischeKlinik II, Universität zu Lübeck, Lübeck, Germany; the 25Department of Health Sciences, University of Leicester, Leicester,U.K.; the 26McKusick-Nathans Institute of Genetic Medicine and Department of Medicine, Johns Hopkins University,Baltimore, Maryland; 27INSERM U70, Villejuif, France; 28University Paris-Sud, Orsay, France; the 29Human GeneticsCenter and Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Houston, Texas; the30Division of Endocrinology and Diabetes, Graduate School Molecular Endocrinology and Diabetes, University of Ulm,Ulm, Germany; the 31Genome Technology Branch, National Human Genome Research Institute, Bethesda,

1050 DIABETES, VOL. 60, MARCH 2011 diabetes.diabetesjournals.org

ERRATA

Maryland; 32Biological Psychology, VU University Amsterdam, Amsterdam, the Netherlands; the 33Department ofMedicine III, Division Prevention and Care of Diabetes, University of Dresden, Dresden, Germany; the 34Department ofMedicine, University of Leipzig, Leipzig, Germany; the 35Centre for Population Health Sciences, University of Edin-burgh, Edinburgh, Scotland; the 36Department of Epidemiology and Public Health, Imperial College London, London,U.K.; the 37Clinical Trials Services Unit, University of Oxford, Oxford, U.K.; the 38Departments of Epidemiology, Bio-statistics, and Medicine, Johns Hopkins University, Baltimore, Maryland; the 39Laboratory of Clinical Investigation,National Institute on Aging, Baltimore, Maryland; 40Cardiovascular Epidemiology and Genetics, Institut MunicipalD’investigacio Medica, and CIBER Epidemiología y Salud Publica, Barcelona, Spain; the 41Clinical Research Branch,National Institute on Aging, Baltimore, Maryland; the 42Division of Endocrinology, Diabetes, and Hypertension, Brighamand Women’s Hospital, Boston, Massachusetts; 43Dipartimento di Ricerca Cardiovascolare, Istituto di RicercheFarmacologiche “Mario Negri,” Milano, Italy; the 44Department of Cardiovascular Medicine, University of Oxford,Oxford, U.K.; 45Immunology and Transfusion Medicine, Ernst Moritz Arndt University Greifswald, Greifswald, Ger-many; the 46Division of Community Health Sciences, St George’s, University of London, London, U.K.; 47CardiovascularSciences, University of Leicester, Leicester, U.K.; the 48Atherosclerosis Research Unit, Department of Medicine,Karolinska Institutet, Stockholm, Sweden; the 49Human Genetics Unit, Medical Research Council, Edinburgh,U.K.; 50Statistical Genetics, Centre National de Genotypage, Evry, France; the 51Institute for Clinical Diabetology,German Diabetes Centre, Leibniz Centre at Heinrich Heine University Düsseldorf, Düsseldorf, Germany; the 52In-terfaculty Institute for Genetics and Functional Genomics, Ernst Moritz Arndt University Greifswald, Greifswald,Germany; the 53Center for Statistical Genetics, University of Michigan School of Public Health, Ann Arbor,Michigan; 54Chronic Disease Prevention, National Institute for Health andWelfare, Turku, Finland; 55LURIC Study nonprofitLLC, Freiburg, Germany; 56Genetics, Drug Discovery, GlaxoSmithKline, King of Prussia, Pennsylvania; 57Statistics,deCODE genetics, Reykjavik, Iceland; the 58National Heart and Lung Institute, Hammersmith Hospital Campus,Imperial College London, London, U.K.; the 59Department of Epidemiology, Johns Hopkins University, Baltimore,Maryland; the 60Interdisciplinary Centre for Clinical Research, University of Leipzig, Leipzig, Germany; the61Department of Medicine, University of Kuopio and Kuopio University Hospital, Kuopio, Finland; 62Centre National deGenotypage, Evry, France; 63Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, Pennsylvania;the 64Department of Clinical Sciences, Lund University, Malmö, Sweden; the 65Department of Medical Epidemiology andBiostatistics, Karolinska Institutet, Stockholm, Sweden; the 66Diabetes and Lipids Research Laboratory, Madrid,Spain; 67Fundación Investigación Biomédica del Hospital Clínico San Carlos, Madrid, Spain; the 68Department of SocialMedicine, University of Bristol, Bristol, U.K.; the 69Institute of Human Genetics, Technische Universität München, München,Germany; the 70Institute of Human Genetics, Helmholtz Zentrum München, German Research Center for Environ-mental Health, Neuherberg, Germany; the 71Department of Genetics, University of North Carolina, Chapel Hill, NorthCarolina; the 72Diabetes Research Center (Diabetes Unit), Massachusetts General Hospital, Boston, Massachusetts;the 73Institute for Clinical Chemistry and Laboratory Medicine, Ernst Moritz Arndt University Greifswald, Greifswald,Germany; the 74Division of Epidemiology and Community Health, University of Minnesota, Minneapolis, Minnesota;the 75Department of Chronic Disease Prevention, National Institute for Health and Welfare, Helsinki, Finland; 76TheInstitute of Molecular Medicine, University of Helsinki, Helsinki, Finland; 77Chronic Disease Prevention, NationalInstitute for Health and Welfare, Helsinki, Finland; 78Andrija Stampar School of Public Health, University of ZagrebMedical School, Zagreb, Croatia; 79Gen-Info Ltd., Zagreb, Croatia; the 80Institute of Biometrics and Epidemiology,German Diabetes Centre, Leibniz Centre at Heinrich Heine University Düsseldorf, Düsseldorf, Germany; the 81De-partment of Human Genetics, Faculty of Medicine, McGill University Montreal, Montreal, Canada; the 82GenomeQuebec Innovation Centre, Montreal, Canada; the 83Department of Metabolic Diseases, Heinrich Heine UniversityDüsseldorf, Düsseldorf, Germany; the 84Croatian Centre for Global Health, University of Split Medical School, Split,Croatia; the 85Gerontology Research Center, National Institute on Aging, Baltimore, Maryland; 86Leibniz-Institut fürArterioskleroseforschung an der Universität Münster, Universität Münster, Münster, Germany; the 87General Medi-cine Division, Massachusetts General Hospital, Boston, Massachusetts; the 88Departments of Medicine and Epide-miology, University of Washington, Seattle, Washington; 89Population Genomics, deCODE genetics, Reykjavik,Iceland; the 90Faculty of Medicine, University of Iceland, Reykjavik, Iceland; the 91LIFE Study Centre, University ofLeipzig, Leipzig, Germany; the 92MedStar Research Institute, Baltimore, Maryland; the 93Institute of Medical In-formatics, Biometry and Epidemiology, Chair of Epidemiology, Ludwig-Maximilians-Universität, Munich, Germany;94Klinikum Grosshadern, Munich, Germany; the 95Department of Neurology, Technische Universität München, München,Germany; the 96Wellcome Trust Case Control Consortium; the 97Center for Applied Genomics, Children’s Hospital ofPhiladelphia, Philadelphia, Pennsylvania; the 98Cardiovascular Research Center and Cardiology Division, Massachu-setts General Hospital, Boston, Massachusetts; 99Public Health and Primary Care, Clinical Gerontology Unit, Universityof Cambridge, Cambridge, U.K.; the 100Pathology Division, Children’s Hospital Boston, Boston, Massachusetts; 101GenomicMedicine, Hammersmith Hospital, Imperial College London, London, U.K.; 102Oxford NIHR Biomedical ResearchCentre, Churchill Hospital, Oxford, U.K.; and 103Epidemiology and Medicine, Johns Hopkins University, Baltimore,Maryland.

In addition, the correct order of corresponding authors is as follows: James B. Meigs, jmeigs@partners.org; Inês Barroso,ib1@sanger.ac.uk; Nicholas J. Wareham, nick.wareham@mrc-epid.cam.ac.uk; Manuela Uda, manuela.uda@inn.cnr.it; andJose C. Florez, jcflorez@partners.org.

diabetes.diabetesjournals.org DIABETES, VOL. 60, MARCH 2011 1051

ERRATA

Racine J, Wang M, Zhang C, Lin C-L, Liu H, Todorov I, Atkinson M, Zeng D. Induction of mixed chimerism with

MHC-mismatched but not matched bone marrow transplants results in thymic deletion of host-type auto-

reactive T-cells in NOD mice. Diabetes 2011;60:555–564

Due to a production error, the incorrect Fig. 2E appeared in the print version of the article listed above. The correctedFig. 2 follows.

The online version reflects these changes.

1052 DIABETES, VOL. 60, MARCH 2011 diabetes.diabetesjournals.org

ERRATA